tiprankstipranks
Celularity (CELU)
NASDAQ:CELU
US Market

Celularity (CELU) Financial Statements

Compare
189 Followers

Celularity Financial Overview

Celularity's market cap is currently $31.90M. The company's EPS TTM is $-1.563; its P/E ratio is ―; Celularity is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue
Gross Profit$ 6.75M$ -1.69M$ 11.68M$ 9.35M
Operating Income$ -192.29M$ -25.60M$ -109.06M$ -151.93M
EBITDA$ -186.96M$ 23.64M$ -88.11M$ -202.41M
Net Income$ -196.29M$ 14.19M$ -100.12M$ -208.23M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―
Total Assets$ 143.89M$ 401.07M$ 414.13M$ 431.01M
Total Debt$ 43.40M$ 65.59M$ 0.00$ 0.00
Net Debt$ 43.17M$ 51.62M$ -37.24M$ -54.31M
Total Liabilities$ 102.93M$ 202.16M$ 314.71M$ 412.30M
Stockholders' Equity$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -39.73M$ -143.11M$ -116.30M$ -91.03M
Operating Cash Flow$ -38.69M$ -137.88M$ -110.10M$ -63.19M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Celularity Earnings and Revenue History

Celularity Debt to Assets

Celularity Cash Flow

Celularity Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis